The Patent Finder

Compositions and Methods for Therapy and Diagnosis of Cancer and Cancer Metastasis

Ganymed Pharmaceuticals AG

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 9,061,007Compositions and Methods for Therapy and Diagnosis of Cancer and Cancer Metastasis
In force
 · Medium confidence
UsedRemaining
BioNTech AGIn forceMedium confidence
Application 12/420,612Compositions and Methods for Therapy and Diagnosis of Cancer and Cancer Metastasis
Abandoned
Abandoned Apr 6, 2013
Ganymed Pharmaceuticals AG, a German Corporation and Johannes Gutenberg-Universitat MainzAbandonedAbandoned Apr 6, 2013
2 of 2 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Ganymed Pharmaceuticals AG.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited